Lenexa, Kansas
United States
22
2024-05-16
16
2020-12-15
These are the the leading inventors for applications assigned to Cydex Pharmaceuticals, Inc.:
Cydex Pharmaceuticals, Inc. based in Lenexa, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
INJECTABLE MELPHALAN COMPOSITIONS COMPRISING A CYCLODEXTRIN DERIVATIVE AND METHODS OF MAKING AND USING THE SAME
#2 | 2020-08-27 ✅ Patent 10,864,183 granted on 2020-12-15Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
#3 | 2017-06-22 ✅ Patent 10,034,947 granted on 2018-07-31Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#4 | 2015-01-22 ✅ Patent 9,125,945 granted on 2015-09-08Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#5 | 2014-08-07 ✅ Patent 10,940,128 granted on 2021-03-09Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
#6 | 2014-07-31 ✅ Patent 11,020,363 granted on 2021-06-01Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
#7 | 2013-10-31 ✅ Patent 8,829,182 granted on 2014-09-09Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
#8 | 2013-05-23 ✅ Patent 8,853,236 granted on 2014-10-07Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#9 | 2012-06-28 ✅ Patent 10,668,160 granted on 2020-06-02DPI formulation containing sulfoalkyl ether cyclodextrin
#10 | 2012-01-26 ✅ Patent 10,463,677 granted on 2019-11-05Composition containing sulfoalkyl ether cyclodextrin and latanoprost
#11 | 2011-10-13Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
#12 | 2011-09-15Treatment of Pulmonary Fungal Infection With Voriconazole via Inhalation
#13 | 2011-05-26Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid
#14 | 2011-01-13Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid Prepared from a Unit Dose Suspension
#15 | 2010-11-18 ✅ Patent 8,343,995 granted on 2013-01-01Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#16 | 2010-04-15 ✅ Patent 8,383,606 granted on 2013-02-26Sulfoalkyl ether cyclodextrin compositions
#17 | 2009-12-17Nasal and Ophthalmic Delivery of Aqueous Corticosteroid Solutions
#18 | 2009-10-29 ✅ Patent 7,635,773 granted on 2009-12-22Sulfoalkyl ether cyclodextrin compositions
#19 | 2009-05-14 ✅ Patent 7,629,331 granted on 2009-12-08Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
#20 | 2009-01-08 ✅ Patent 8,049,003 granted on 2011-11-01Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
#21 | 2007-08-02 ✅ Patent 8,114,438 granted on 2012-02-14DPI formulation containing sulfoalkyl ether cyclodextrin
#22 | 2005-08-25 ✅ Patent 7,829,114 granted on 2010-11-09Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
Also check out Cydex Pharmaceuticals, Inc.'s (Lenexa, United States) applicant profile with 9 patent applications submitted.
23967 ⎘